Cardiol Net Tangible Assets from 2010 to 2025
| CRDL Stock | CAD 1.44 0.03 2.04% |
Net Tangible Assets | First Reported 2018-06-30 | Previous Quarter 51.9 M | Current Value 38.5 M | Quarterly Volatility 22.3 M |
Check Cardiol Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardiol Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 607.6 K, Interest Income of 3 M or Depreciation And Amortization of 190.7 K, as well as many indicators such as Price To Sales Ratio of 1 K, Dividend Yield of 0.0 or PTB Ratio of 8.31. Cardiol financial statements analysis is a perfect complement when working with Cardiol Therapeutics Valuation or Volatility modules.
Cardiol | Net Tangible Assets |
Check out the analysis of Cardiol Therapeutics Correlation against competitors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.